Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

Not leaving ourselves much room for a graceful transition over to B-UC if B-COVID doesn't work out.

How far we've come from a three-pronged behemoth of a clinical pipeline ready for partnership and phase 3 in 2015 to a crap shoot based on preclinical COVID testing as we enter 2021.

I guess you're right in a way. No sense worrying about a B-COVID failure at this point. Blow on those dice and hope for a new pair of shoes my fellow gamblers.

Go IPIX!